Therapeutic Product Immunogenicity Community

The AAPS Journal Theme Issue: Compendium of Immunogenicity Risk Assessments: an Industry Guidance Built on Experience and Published Work - The AAPS Journal SpringerLink remove preview The AAPS Journal Theme Issue: Compendium of Immunogenicity Risk Assessments: an Industry Guidance Built on Experience and Published Work - The AAPS Journal The AAPS Journal 25, Article number: 43 (2023) Cite this article For nearly 20 years ( 1, 2), a risk-based approach to assess immunogenic potential and resultant clinical consequences of administration of therapeutic proteins has evolved to what we practice today. View this on SpringerLink >

To view the full article through your AAPS membership:

Go to https://www.aaps.org/education-and-research/journals/the-aaps-journal. Click or tap if you trust this link." rel="noopener">https://www.aaps.org/education-and-research/journals/the-aaps-journal 

Enter your AAPS credentials

Click "Member Access to Journals"

Click on the The AAPS Journal cover.

Copy and paste the url into the "Search" box, and click search

The full article should appear.

Follow The AAPS Journal via Twitter https://twitter.com/theaapsjournal?lang=en, and

Linkedin,  https://www.linkedin.com/in/the-aaps-journal-07a6b719b

------------------------------
Ho-Leung Fung Ph.D., FAAPS
Editor-in-Chief
University at Buffalo
Sarasota FL
[email protected]

Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------